trial · primary record
IBI363
Melanoma
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 203 |
| Primary completion | 2027-12-31 |
| Primary endpoint | IRRC-Progression Free Survival(PFS) |
| Registry ID | NCT06797297 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:24.196Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06797297
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.